Predictors of Blood Transfusion in Deep Inferior Epigastric Artery Perforator Flap Breast Reconstruction

ABSTRACT

Perioperative blood loss during and following breast reconstruction surgery can have substantial impact on free flap survival and patient morbidity. Transfusion rates of up to 95% have been reported following transverse rectus abdominis myocutaneous flap breast reconstruction, with blood loss described as significant in most cases. However, there has been little reported of such requirements in patients undergoing deep inferior epigastric perforator (DIEP) flap breast reconstruction. We present the transfusion requirements of 152 consecutive patients who underwent DIEP flap breast reconstruction, with a view to quantifying transfusion requirements and identifying risk factors for such loss. In this cohort, 80.3% of patients required blood transfusion, with a mean volume of 3.9 U per patient. There was a statistically significant correlation for increased transfusion requirement in patients with preoperative anemia (p < 0.001) and in bilateral cases (p < 0.001), but not for cases of immediate reconstruction (p = 0.72). Although blood loss in breast reconstructive surgery is rarely large enough to be life-threatening, relative anemia does have significant effect on flap survival and patient morbidity. With risk factors for increased transfusion requirements identified in the current study, high-risk patients can be predicted preoperatively.

Blood loss - abdominal wall - perforator flap - bleeding - free flap - complications

REFERENCES

• 1 Weber R S, Jabbour N, Martin II R CG. Anemia and transfusions in patients undergoing surgery for cancer.  Ann Surg Oncol. 2008;  15 34-45
• 2 Groopman J E, Itri L M. Chemotherapy-induced anemia in adults: incidence and treatment.  J Natl Cancer Inst. 1999;  91 1616-1634
• 3 Eberlein T J, Crespo L D, Smith B L, Hergrueter C A, Douville L, Eriksson E. Prospective evaluation of immediate reconstruction after mastectomy.  Ann Surg. 1993;  218 29-36
• 4 Elliott L F, Eskenazi L, Beegle P H et al.. Immediate TRAM flap breast reconstruction: 128 consecutive cases.  Plast Recon Surg. 1993;  92 217-227
• 5 Jacobsen W M, Meland N B, Woods J E. Autologous breast reconstruction with use of transverse rectus abdominis musculocutaneous flap: Mayo clinic experience with 147 cases.  Mayo Clin Proc. 1994;  69 635-640
• 6 Khouri R K, Ahn C Y, Salzhauer M A, Scherff D, Shaw W W. Simultaneous bilateral breast reconstruction with the transverse rectus abdominus musculocutaneous free flap.  Ann Surg. 1997;  226 25-34
• 7 Lennox P A, Clugston P A, Beasley M E, Bostwick III J. Autologous blood transfusion in TRAM breast reconstruction: is it necessary?.  Ann Plast Surg. 2004;  53 532-535
• 8 Rinker B D, Bowling J T, Vasconez H C. Blood transfusion and risk of metastatic disease or recurrence in patients undergoing immediate TRAM flap breast reconstruction: a clinical study and meta-analysis.  Plast Reconstr Surg. 2007;  119 2001-2007
• 9 Vega S J, Nguyen T V, Forsberg C et al.. Efficacy of preoperative autologous blood donation in free TRAM flap breast reconstruction.  Plast Reconstr Surg. 2008;  121 241e-246e
• 10 Holley D T, Toursarkissian B, Vásconez H C et al.. The ramifications of immediate reconstruction in the management of breast cancer.  Am Surg. 1995;  61 60-65
• 11 Vamvakas E C. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation.  Transfusion. 1995;  35 760-768
• 12 Voogt P J, van de Velde C JH, Brand A et al.. Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients.  Cancer. 1987;  59 836-843
• 13 Gantt C L. Red blood cells for cancer patients.  Lancet. 1981;  2 363
• 14 Ames S A, Shelby J, Roberts L K, Nelson E W. Factors in transfusion-related enhanced tumor growth.  Transplant Proc. 1988;  20 1121-1124
• 15 Blajchman M A, Bordin J O. Mechanisms of transfusion-associated immunosuppression.  Curr Opin Hematol. 1994;  1 457-461
• 16 Kirkley S A. Proposed mechanisms of transfusion-induced immunomodulation.  Clin Diagn Lab Immunol. 1999;  6 652-657
• 17 Opelz G, Sengar D P, Mickey M R et al.. Effect of blood transfusions on subsequent kidney transplants.  Transplant Proc. 1973;  5 253-259
• 18 Crowe J P, Gordon N H, Fry D E, Shuck J M, Hubay C A. Breast cancer survival and perioperative blood transfusion.  Surgery. 1989;  106 836-841
• 19 Herman K, Kolodziejski L. Blood transfusion and survival after surgery for stage I and II breast cancer.  Neoplasma. 1993;  40 117-125
• 20 Hoe N Y, Herman K J, Hermann R E, Medendorp S V. Perioperative blood transfusion and survival of breast cancer patients after modified radical mastectomy.  Cleve Clin J Med. 1991;  58 515-519
• 21 Tartter P I, Burrows L, Papatestas A E, Lesnick G, Aufses Jr A H. Perioperative blood transfusion has prognostic significance for breast cancer.  Surgery. 1985;  97 225-230
• 22 Tzilinis A, Lofman A M, Tzarnas C D. Transfusion requirements for TRAM flap postmastectomy breast reconstruction.  Ann Plast Surg. 2003;  50 623-627
• 23 Paige K T, Bostwick III J, Bried J T. TRAM flap breast reconstruction: tumescent technique reduces blood loss and transfusion requirement.  Plast Reconstr Surg. 2004;  113 1645-1649
• 24 Baldwin B J, Schusterman M A, Miller M J, Kroll S S, Wang B G. Bilateral breast reconstruction: conventional versus free TRAM.  Plast Reconstr Surg. 1994;  93 1410-1416 discussion 1417
• 25 Drazan L, Vesely J, Hyza P et al.. Bilateral breast reconstruction with DIEP flaps: 4 years' experience.  J Plast Reconstr Aesthet Surg. 2008;  61 1309-1315
• 26 Hamdi M, Weiler-Mithoff E M, Webster M H. Deep inferior epigastric perforator flap in breast reconstruction: experience with the first 50 flaps.  Plast Reconstr Surg. 1999;  103 86-95
• 27 Takeishi M, Fujimoto M, Ishida K, Makino Y. Muscle sparing-2 transverse rectus abdominis musculocutaneous flap for breast reconstruction: a comparison with deep inferior epigastric perforator flap.  Microsurgery. 2008;  28 650-655
• 28 Clugston P A, Fitzpatrick D G, Kester D A, Foley B, Germann E. Autologous blood use in reduction mammaplasty: is it justified?.  Plast Reconstr Surg. 1995;  95 824-828
• 29 Crosby E T, Murphy P, Benoit P R. Routine predeposit of autologous blood is not warranted before breast reduction surgery.  Can J Surg. 1995;  38 309-313
• 30 Arnez Z M, Bajec J, Bardsley A F, Scamp T, Webster M H. Experience with 50 free TRAM flap breast reconstructions.  Plast Reconstr Surg. 1991;  87 470-478 discussion 479-482
• 31 Elliott L F, Seify H, Bergey P. The 3-hour muscle-sparing free TRAM flap: safe and effective treatment review of 111 consecutive free TRAM flaps in a private practice setting.  Plast Reconstr Surg. 2007;  120 27-34

1 All authors contributed significantly to this work.